GlassScriptPhysician profile
Camille Picini
NPI 1932750114
$30,816.23
in general payments reported to CMS, 2019-2025
28 companies · $8,245 in 2025
The $8,245 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,643 · 2022: $4,410 · 2023: $4,636 · 2024: $9,881 · 2025: $8,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Consulting Fee: $3,840 · Travel and Lodging: $994 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,719.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Consulting Fee | $3,840.00 |
| Travel and Lodging | $994.05 |
| Education | $208.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $11,308.34 | 2021-2025 | Bimzelx, Cimzia |
| Amgen INC. | $4,369.27 | 2021-2025 | Tavneos, Evenity, Krystexxa |
| Abbvie INC. | $2,894.27 | 2021-2025 | |
| Janssen Biotech, INC. | $2,359.15 | 2021-2025 | Tremfya, Simponi, Stelara |
| Mallinckrodt Hospital Products INC. | $2,290.84 | 2021-2025 | Acthar |
| Pfizer INC. | $917.61 | 2021-2025 | |
| Radius Health, INC. | $890.08 | 2021-2025 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $786.27 | 2021-2025 | Saphnelo, Flumist Quadrivalent, Evusheld |
| Novartis Pharmaceuticals Corporation | $767.15 | 2021-2025 | |
| Glaxosmithkline, LLC. | $745.11 | 2021-2025 | Benlysta |
| Ani Pharmaceuticals, INC. | $638.26 | 2022-2024 | Purified Cortrophin Gel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $451.46 | 2021-2025 | Cyltezo, Ofev |
| Genentech USA, INC. | $442.53 | 2021-2025 | Actemra |
| Aurinia Pharma U.S., INC. | $416.03 | 2021-2025 | Lupkynis |
| E.R. Squibb & Sons, L.L.C. | $223.99 | 2021-2025 | Orencia |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $171.48 | 2025 | Tremfya |
| Depuy Synthes Sales INC. | $162.99 | 2021-2024 | Orthovisc, Monovisc |
| Bioventus LLC | $153.11 | 2022-2024 | Gelsyn-3 |
| Alexion Pharmaceuticals, INC. | $145.85 | 2024-2025 | Strensiq |
| Fresenius Kabi USA, LLC | $133.89 | 2023-2024 | Idacio |
| Horizon Therapeutics Plc | $133.55 | 2021-2023 | Krystexxa |
| Lilly USA, LLC | $87.97 | 2021-2024 | Taltz, Zepbound |
| Sandoz INC. | $66.99 | 2023-2025 | Hyrimoz |
| Scilex Pharmaceuticals INC. | $66.36 | 2025 | |
| Genzyme Corporation | $66.06 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $61.96 | 2021-2024 | Euflexxa |
| Ultragenyx Pharmaceutical INC. | $41.67 | 2022-2023 | Crysvita |
| Alvogen INC | $23.99 | 2025 | Teriparatide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camille Picini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.